Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab in Combination With Concurrent Chemoradiotherapy for Local-regional Recurrent Nasopharyngeal Carcinoma: a Phase 3, Multicentre, Randomised Controlled Trial

NCT04376866 is registered in ClinicalTrials.gov with Cancer Hospital of Guangxi Medical University as lead sponsor.

NCT NCT04376866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04376866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab in Combination With Concurrent Chemoradiotherapy for Local-regional Recurrent Nasopharyngeal Carcinoma: a Phase 3, Multicentre, Randomised Controlled Trial
Lead sponsor
Cancer Hospital of Guangxi Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
June 28, 2020
Completion date
April 30, 2028
Enrollment
204 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent nasopharyngeal carcinoma